DOPAMINE D2 AND D3 RECEPTOR OCCUPANCY OF CARIPRAZINE IN SCHIZOPHRENIC PATIENTS

被引：0
|
作者：
Keator, David B. [1 ]
Mukherjee, J. [1 ]
Preda, A. [1 ]
Highum, D. [1 ]
Lakatos, A. [1 ]
Gage, A. [2 ]
Potkin, S. G. [1 ]
机构：
[1] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA
[2] Forest Res Inst, Jersey City, NJ USA
来源：
SCHIZOPHRENIA BULLETIN | 2009年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [21] Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor
    Annika Frank
    Dóra J. Kiss
    György M. Keserű
    Holger Stark
    [J]. Scientific Reports, 8
  • [22] Dopamine D3 receptor density and occupancy determined with selective D3 inhibitor and [11C]raclopride (D2/D3) PET.
    Wong, DF
    Gjedde, A
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 256P - 256P
  • [23] Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI
    Sander, Christin Y.
    Hooker, Jacob M.
    Catana, Ciprian
    Normandin, Marc D.
    Alpert, Nathaniel M.
    Knudsen, Gitte M.
    Vanduffel, Wim
    Rosen, Bruce R.
    Mandeville, Joseph B.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (27) : 11169 - 11174
  • [24] Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor
    Frank, Annika
    Kiss, Dora J.
    Keseru, Gyorgy M.
    Stark, Holger
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [25] Occupancy of Striatal and Extrastriatal Dopamine D2/D3 Receptors by Olanzapine and Haloperidol
    Robert M Kessler
    Mohammad Sib Ansari
    Patrizia Riccardi
    Rui Li
    Karuna Jayathilake
    Benoit Dawant
    Herbert Y Meltzer
    [J]. Neuropsychopharmacology, 2005, 30 : 2283 - 2289
  • [26] Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol
    Kessler, RM
    Ansari, MS
    Riccardi, P
    Li, R
    Jayathilake, K
    Dawant, B
    Meltzer, HY
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 (12) : 2283 - 2289
  • [27] The dopamine D3-preferring D2/D3 dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia
    Watson, David J. G.
    King, Madeleine V.
    Gyertyan, Istvan
    Kiss, Bela
    Adham, Nika
    Fone, Kevin C. F.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (02) : 208 - 224
  • [28] Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
    Kiss, Bela
    Horvath, Attila
    Nemethy, Zsolt
    Schmidt, Eva
    Laszlovszky, Istvan
    Bugovics, Gyula
    Fazekas, Karoly
    Hornok, Katalin
    Orosz, Szabolcs
    Gyertyan, Istvan
    Agai-Csongor, Eva
    Domany, Gyoergy
    Tihanyi, Karoly
    Adham, Nika
    Szombathelyi, Zsolt
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01): : 328 - 340
  • [29] Cariprazine, A Dopamine D2/D3 Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer
    Hussein, Noor
    Ashby, Charles R., Jr.
    Amawi, Haneen
    Nyinawabera, Angelique
    Vij, Atul
    Khare, Vishwa M.
    Karthikeyan, Chandrabose
    Tiwari, Amit K.
    [J]. CANCERS, 2018, 10 (09)
  • [30] Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
    Chien, Ellen Y. T.
    Liu, Wei
    Zhao, Qiang
    Katritch, Vsevolod
    Han, Gye Won
    Hanson, Michael A.
    Shi, Lei
    Newman, Amy Hauck
    Javitch, Jonathan A.
    Cherezov, Vadim
    Stevens, Raymond C.
    [J]. SCIENCE, 2010, 330 (6007) : 1091 - 1095
12345